Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.


TSXV:AVCR - Post by User

Bullboard Posts
Comment by ElectricFuneralon Dec 09, 2015 3:32pm
142 Views
Post# 24370308

RE:RE:RE:RE:RE:big push down....

RE:RE:RE:RE:RE:big push down....
Sdmsdm wrote: Your wrong again. At least $0.5m inventory has been added in the last couple of months. Even a cursory look at the financials will tell you that.

You really are not very good at this are you? Maybe that one pager the basher boss gave you doesn't contain very good facts?

McKesson hasn't stopped them from signing deals with London Drugs, Jean Coutu and multiple other national chains. 

Do you understand the difference between SALES and marketing?  Look it up, it might stop you making such a knob of yourself of a public forum again. 

No idea where the price goes in the next few days and dont particularly care. 



After they received their first shipment, 6 months plus have past. So, if I was an investor, I would rather see low inventory, that would mean good sales. When generics are on the warehouse shelves, they are not into pharma. Just that fact should tell you a lot. You can't count it in your inventory if its in a drug store. You can have as many deal with all the pharma in this world, but one thing is for sure, big players have the money to stop you from getting in. Do you still need me to explain you that too? If so, please ask and I'll reply. You the difference between a pumper/basher and me? I have arguments like you do. Your the only one who discuss with me and have some arguments to back you up. Normally it's: put him on ignore, get lost, liar, stupid, etc..... Anything but good info.
Bullboard Posts